Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$692.8M
-21.0% from 2023
Prescriptions
389K
$1,779.56 per claim
Patients
55K
14,008 prescribers
Total spending, 2024
$692.9M
$12,535.66 per patient
Medicare prescription drug plans paid $692.8M for Abiraterone Acetate in 2024, for 389,330 prescriptions and refills to 55,268 patients (down 21.0% from 2023). The average cost per claim was $1,779.56.
New York had the highest Medicare cost for Abiraterone Acetate in 2024: $78.9M for 30,331 claims, followed by California ($58.8M).
Benjamin A Gartrell, medical oncology in Bronx, NY, had the highest Medicare cost for Abiraterone Acetate in 2024: 660 claims costing $1.9M.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Benjamin A Gartrell Bronx, NY | Medical Oncology | 660 | 93 | $1.9M |
| Michael S Humeniuk Spartanburg, SC | Internal Medicine | 682 | 88 | $1.9M |
| Thad A Bourque |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 11,021 | 230,073 | 35,730 | $701.8M |
| 2023 | 12,545 | 315,523 | 45,624 | $877.0M |
| 2024 | 14,008 | 389,330 | 55,268 | $692.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Urology |
| 897 |
| 149 |
| $1.8M |
| Emerson A Lim Grand Rapids, MI | Medical Oncology | 504 | 76 | $1.8M |
| Eric D Batts Holland, MI | Hematology-Oncology | 498 | 79 | $1.5M |
| Sukumar Ethirajan Overland Park, KS | Hematology | 923 | 127 | $1.5M |
| Michael J Kane Waterford, CT | Internal Medicine | 353 | 44 | $1.4M |
| Jennifer Arnold Williamsville, NY | Physician Assistant | 494 | 73 | $1.4M |
| Deaglan McHugh New York, NY | Medical Oncology | 397 | 62 | $1.3M |
| Douglas E Feeney Fairfield, OH | Urology | 622 | 73 | $1.3M |
| Elan Diamond Bloomfield, NJ | Hematology-Oncology | 735 | 110 | $1.3M |
| Caitlin Shepherd Oklahoma City, OK | Urology | 457 | 59 | $1.3M |
| John M Rutkowski Sanborn, NY | Urology | 400 | 68 | $1.2M |
| Antony Ruggeri Milwaukee, WI | Hematology-Oncology | 530 | 70 | $1.2M |
| Benjamin J Martin Gahanna, OH | Urology | 627 | 77 | $1.2M |
| Christian A Thomas Westbrook, ME | Hematology-Oncology | 454 | 70 | $1.1M |
| Christian M Squillante Voorhees, NJ | Hematology-Oncology | 375 | 55 | $1.1M |
| Thomas Bradley Lake Success, NY | Medical Oncology | 329 | 48 | $1.1M |
| Qamar S Khan Kissimmee, FL | Hematology-Oncology | 329 | 42 | $1.0M |
| Susan F Slovin New York, NY | Medical Oncology | 424 | 70 | $994K |
| Scott E Delacroix Metairie, LA | Urology | 303 | 37 | $991K |
| Benjamin H Lowentritt Baltimore, MD | Urology | 359 | 69 | $978K |
| Jacqueline K Smith Spartanburg, SC | Nurse Practitioner | 402 | 72 | $969K |
| Hank Ng New York, NY | Medical Oncology | 387 | 48 | $958K |
| Alexandra N Francino New Hyde Park, NY | Physician Assistant | 237 | 43 | $957K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novadoz Pharmac | 154,465 | $198.4M |
| Novugen Pharma | 25,486 | $91.5M |
| Glenmark Pharma GLENMARK.NS | 35,259 | $89.1M |
| Apotex Corp | 35,117 | $82.8M |
| Amneal Pharmace AMRX | 21,522 | $77.9M |
| Northstar Rx Ll | 26,215 | $37.2M |
| Florida Pharmac | 25,850 | $36.8M |
| Bluepoint/Oncop | 13,000 | $22.6M |
| Dr.Reddy'S Lab RDY | 3,998 | $15.2M |
| Mylan VTRS | 3,541 | $13.5M |
| Rising Pharm | 5,003 | $13.2M |
| West-Ward/Hikma HIK.L | 32,545 | $5.3M |
| Celltrion USA, | 1,685 | $4.5M |
| Quallent Pharma | 975 | $2.8M |
| Teva USA TEVA | 423 | $1.4M |
| Civicascript, L | 3,989 | $624K |
| Major Pharmaceu | 284 | $77K |
| AHP | 11 | $7,452 |